StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.70−0.05 (-6.46%)

Close on Oct 19, 2026Market cap $1.45MP/E –Yield –

Bluejay Diagnostics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Bluejay Diagnostics's free cash flow for the twelve months ending Dec 31, 2024 was -$8.13M. For fiscal 2025 it was -$6.23M. The highest annual figure on record is -$4.39M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.23M–
FY2024Dec 31, 2024-$8.13M–
FY2023Dec 31, 2023-$9.02M–
FY2022Dec 31, 2022-$8.94M–
FY2021Dec 31, 2021-$4.39M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.64M–
Q1 FY2026Mar 31, 2026-$1.61M–
Q4 FY2024Dec 31, 2024-$1.45M–
Q3 FY2024Sep 30, 2024-$2.15M–
Q2 FY2024Jun 30, 2024-$2.18M–
Q1 FY2024Mar 31, 2024-$2.34M–
Q4 FY2023Dec 31, 2023-$2.87M–
Q3 FY2023Sep 30, 2023-$1.20M–
Q2 FY2023Jun 30, 2023-$1.68M–
Q1 FY2023Mar 31, 2023-$3.27M–
Q4 FY2022Dec 31, 2022-$3.18M–
Q3 FY2022Sep 30, 2022-$2.05M–
Q2 FY2022Jun 30, 2022-$1.78M–
Q1 FY2022Mar 31, 2022-$1.92M–
Q4 FY2021Dec 31, 2021-$2.54M–
Q3 FY2021Sep 30, 2021-$1.12M–

More Bluejay Diagnostics figures

See a number that looks wrong?